Online inquiry

IVTScrip™ mRNA-Human ADAM9, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK12497MR)

This product GTTS-WK12497MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADAM9 protein. This product can be used in Microglial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_003816.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 8754
UniProt ID Q13443
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADAM9, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK12497MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK24395MR IVTScrip™ mRNA-Human ARHGAP30, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARHGAP30
GTTS-WK14330MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK15229MR IVTScrip™ mRNA-Human ANKRD49, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD49
GTTS-WK18860MR IVTScrip™ mRNA-Human ANXA2R, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANXA2R
GTTS-WK11074MR IVTScrip™ mRNA-Human ADTRP, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ADTRP
GTTS-WK10782MR IVTScrip™ mRNA-Human AFF1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AFF1
GTTS-WK16937MR IVTScrip™ mRNA-Human alpha-SMA, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA alpha-SMA
GTTS-WK11268MR IVTScrip™ mRNA-Human ACTR10, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ACTR10
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW